However, hepcidin levels were very low in the IDA control group (i.e., <0.5 nM) despite the presence of conditions that could stimulate hepcidin production relative to TSAT (e.g., obesity and mild to moderate chronic kidney disease) [8,24,31]. The gene discussed is HAMP; the disease is Obesity.